This course is designed as a source of advisement for entities and individuals navigating their health and that of the wider public based on civil/corporate responsibility.

This course in its original intent will:

i. Highlight the physiological risks of operating in such a society, even with existing topical safety measures

ii. Allow for Physical and Technical facilitation of such environments

iii. Identify, with the intention to Utilize natural (non-Toxic) and pharmaceutical agents proven to combat significant ill effects caused by COVID-19

iv. Discuss the suitability of the indicated agents based on intended environments and recipients

v. Create prophylactic packages based on key negotiating health factors

vi. Discuss key Maintenance factors based on implemented course of action in order to facilitate elasticity and scalability

vii. Review and Discuss Cost-Benefit for Executives and Administrators